After receiving her degree from the University of California San Diego School of Medicine, Dr. Youdim completed her residency ...

Oral GLP-1 drugs have been around for a few years, but formulations specifically for weight loss are new, and a new pill is ...

U.S. market will not open until patent expires in 2032, but individual generics can be sold in Canada once approved ...

Semaglutide is an injectable drug formulated for the treatment of type 2 diabetes, but it’s since become increasingly popular ...

WESTON, Fla., April 10, 2026 /PRNewswire/ - Apotex Corp. today announced it has received the first U.S. Food and Drug Administration (FDA) Tentative Approval for its Abbreviated New Drug Application ...

Scientists found a key to Ozempic’s rise in Gila monster venom, leading to Byetta and the modern era of GLP-1 diabetes and ...

From hidden side effects and muscle loss to pregnancy risks and fake injections, 6 top doctors answer the internet’s biggest ...

GLP-1 drugs like Ozempic have long helped people eat less — now, they’re showing promise in helping people crave less. A new analysis of records from over 600,000 diabetic veterans found that GLP-1 ...

Health Canada ‌​approved on Tuesday the first generic ​version of ​Danish drugmaker Novo ‌Nordisk's Ozempic drug.

Sanjeev Sockalingam, the scientific director of Obesity Canada, a non-profit patient advocacy and research group, said he hopes the arrival of cheaper generics will prod Canadian public drug plans and ...

Ozempic (semaglutide) is Food and Drug Administration (FDA)-approved for type 2 diabetes. It may be prescribed off-label to help manage weight and metabolic concerns in people with polycystic ovary ...

GLP-1 drugs like Ozempic have long helped people eat less — now, they’re showing promise in helping people crave less. A new analysis of records from over 600,000 diabetic veterans found that GLP-1 ...